Related Experiment Video
Updated: Nov 10, 2025

Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
Immune Negative Regulator TIPE2 Inhibits Cervical Squamous Cancer Progression Through Erk1/2 Signaling
Li-Qiong Huang1, Bo Zheng1, Yi He1
1Department of Obstetrics and Gynecology, Xianning Central Hospital, The First Affiliated Hospital of Hubei University of Science and Technology, 228 Jingui Road, Xianning 437100, China.
Abstract:
Tumor necrosis factor (TNF)-α-induced protein-8-like 2, or TIPE2, is a newly found immune negative regulatory molecule. This study further investigated the role of TIPE2 on proliferation and invasion of cervical squamous cancer cells. Expression of TIPE2 was compared in cervical squamous cancer tissues and adjacent normal tissues by Western blot and immunohistochemistry (IHC). Cervical squamous cancer cell lines, SiHa and C33A, were transfected with recombinant plasmid encoding TIPE2 and tested for cytologic characteristics. The impact of TIPE2 on phosphorylation of extracellular signal-regulated kinase (Erk) signaling pathway was also tested by Western blot analysis of key factors. TIPE2 expression was higher in cervical cancer tissues than that in normal tissue. IHC score of tumor tissue was negatively associated with lymphatic metastasis. Over expression of TIPE2 effectively inhibited the proliferation of cervical cancer cells. Wound healing and transwell assay showed that over expression of TIPE2 suppressed cell migration and invasion in vitro. Meanwhile, phosphorylation of Erk1/2 and upstream mitogen-activated protein kinase kinase (MEK) 1/2 was reduced by TIPE2. TIPE2 is negatively related with development of cervical squamous cancer. TIPE2 is an inhibitory factor of proliferation and invasion of cervical squamous cancer cells, probably through inhibiting Erk signaling pathway.
Insights
Tumor necrosis factor-α-induced protein-8-like 2 (TIPE2) inhibits cervical cancer cell growth and spread. Higher TIPE2 levels in tumors correlate with less metastasis, suggesting TIPE2
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Tumor necrosis factor-α-induced protein-8-like 2 (TIPE2) is an immune negative regulator.
- The role of TIPE2 in cervical squamous cancer progression requires further investigation.
Purpose of the Study:
- To investigate the function of TIPE2 in cervical squamous cancer cell proliferation and invasion.
- To explore the association between TIPE2 expression and clinicopathological features, including lymphatic metastasis.
- To elucidate the mechanism by which TIPE2 affects the extracellular signal-regulated kinase (Erk) signaling pathway.
Main Methods:
- Western blot and immunohistochemistry (IHC) were used to assess TIPE2 expression in cervical cancer tissues and cell lines (SiHa, C33A).
- Cell lines were transfected with a TIPE2-encoding plasmid to study its effects on proliferation, migration, and invasion.
- Western blot analysis was performed to examine the phosphorylation status of Erk1/2 and MEK1/2 signaling pathway components.
Main Results:
- TIPE2 expression was significantly higher in cervical cancer tissues compared to normal tissues.
- Higher IHC scores for TIPE2 in tumors were negatively correlated with lymphatic metastasis.
- Overexpression of TIPE2 suppressed cervical cancer cell proliferation, migration, and invasion in vitro.
- TIPE2 overexpression reduced the phosphorylation of Erk1/2 and MEK1/2, indicating inhibition of the Erk signaling pathway.
Conclusions:
- TIPE2 expression is negatively associated with the development and progression of cervical squamous cancer.
- TIPE2 acts as an inhibitory factor for cervical squamous cancer cell proliferation and invasion.
- The inhibitory effects of TIPE2 may be mediated through the suppression of the Erk signaling pathway.
Related Concept Videos
Negative Regulator Molecules
Inhibition of Cdk Activity
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation
Mitogens and the Cell Cycle
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

